Neuraxis, Inc. Files 8-K with Material Agreements and Officer Changes
Ticker: NRXS · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1933567
| Field | Detail |
|---|---|
| Company | Neuraxis, INC (NRXS) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, officer-changes, corporate-action
TL;DR
Neuraxis 8-K: Material agreements entered & terminated, plus exec changes. Watch closely.
AI Summary
Neuraxis, Inc. filed an 8-K on July 3, 2025, reporting on several key events as of July 1, 2025. These include entering into a material definitive agreement, terminating a material definitive agreement, and changes in directors and officers, including compensatory arrangements. The filing also covers financial statements and exhibits.
Why It Matters
This 8-K filing signals significant corporate actions at Neuraxis, Inc., including changes in agreements and personnel, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — The filing indicates significant corporate actions, including the termination of a material agreement and changes in officers, which could introduce uncertainty.
Key Players & Entities
- Neuraxis, Inc. (company) — Registrant
- July 1, 2025 (date) — Earliest event reported
- July 3, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 45-5079684 (identifier) — I.R.S. Employer Identification No.
- 11550 N. Meridian Street , Suite 325 Carmel , IN 46032 (address) — Principal executive offices
FAQ
What specific material definitive agreement was entered into by Neuraxis, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What specific material definitive agreement was terminated by Neuraxis, Inc.?
The filing indicates the termination of a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What are the key changes in directors or officers reported in this 8-K?
The filing reports on the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as compensatory arrangements for certain officers, but specific names are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 1, 2025.
What is the principal executive office address for Neuraxis, Inc.?
The principal executive office address for Neuraxis, Inc. is 11550 N. Meridian Street, Suite 325, Carmel, IN 46032.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding Neuraxis, INC (NRXS).